Literature DB >> 6689042

The perfused rat lung as a model for studies on the formation of surfactant and the effect of Ambroxol on this process.

M Post, J J Batenburg, E A Schuurmans, V Oldenborg, A J van der Molen, L M van Golde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6689042     DOI： 10.1007/bf02713884

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  30 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Composition and metabolism of phospholipids of Fasciola hepatics, the common liver fluke.

Authors:  V Oldenborg; F Van Vugt; L M Van Golde
Journal:  Biochim Biophys Acta       Date:  1975-07-22

3.  [Enhancing the production of alveolar surfactant using NA 872].

Authors:  P C Curti
Journal:  Pneumonologie       Date:  1972

4.  Fatty acid synthesis in the perfused rat lung.

Authors:  K F Buechler; R A Rhoades
Journal:  Biochim Biophys Acta       Date:  1980-08-11

5.  Influence of transplacental NA-872 and dexamethasone therapy on fetal and newborn mouse lung.

Authors:  B J Velásquez; J Sepúlveda
Journal:  Respiration       Date:  1982       Impact factor: 3.580

6.  Changes in sedimentation of surfactant in ventilated excised rat lungs. Physical alterations in surfactant associated with the development and reversal of atelectasis.

Authors:  L A Thet; L Clerch; G D Massaro; D Massaro
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

7.  Effects of cortisol and thyroxine on phosphatidylcholine and phosphatidylglycerol synthesis by adult rat lung alveolar type II cells in primary culture.

Authors:  M Post; J J Batenburg; L M van Golde
Journal:  Biochim Biophys Acta       Date:  1980-05-28

8.  Effects of metabolite VIII of bromexine (Na 872) on type II epithelium of the lung: an experimental and morphological study with reference to surfactant secretion.

Authors:  P Cerutti; Y Kapanci
Journal:  Respiration       Date:  1979       Impact factor: 3.580

9.  Pathways of palmitate metabolism in the isolated rat lung.

Authors:  D J Bassett; M Hamosh; P Hamosh; J L Rabinowitz
Journal:  Exp Lung Res       Date:  1981-03       Impact factor: 2.459

10.  The perfused isolated lung as a possible model for the study of lipid synthesis by type II cells in their natural environment.

Authors:  J J Batenburg; M Post; V Oldenborg; L M Van Golde
Journal:  Exp Lung Res       Date:  1980-03       Impact factor: 2.459
View more
  7 in total

1.  Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo.

Authors:  G Fegiz
Journal:  Lung       Date:  1991       Impact factor: 2.584

2.  The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant.

Authors:  M F Heath; W Jacobson
Journal:  Lung       Date:  1985       Impact factor: 2.584

3.  Ambroxol - Resurgence of an old molecule as an anti-inflammatory agent in chronic obstructive airway diseases.

Authors:  P R Gupta
Journal:  Lung India       Date:  2010-04

4.  Effect of ambroxol of neutrophil chemotaxis in vitro.

Authors:  R A Stockley; J Shaw; D Burnett
Journal:  Agents Actions       Date:  1988-07

Review 5.  Pulmonary alveolar type II epithelial cells and adult respiratory distress syndrome.

Authors:  R J Mason
Journal:  West J Med       Date:  1985-11

6.  Ambroxol lozenge bioavailability : an open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy thai volunteers.

Authors:  Malee Rojpibulstit; Srirat Kasiwong; Siwasak Juthong; Narubodee Phadoongsombat; Damrongsak Faroongsarng
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

7.  The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats.

Authors:  Xiwen Gao; Yi Huang; Yipin Han; Chun-Xue Bai; Guifang Wang
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.